Tag:
obesity
Latest Headlines
Latest Headlines
Allergan to enlist new hires in R&D expansion
Allergan has ambitious plans to swell its ranks with the opening of a new R&D facility in the Garden State. The news comes amid a major push at Allergan to expand the use of Botox far beyond fixing facial wrinkles and to develop therapies for a variety of ailments.
FDA panel wants higher standard for obesity-treating devices
If the risk is higher, the reward should be, too. That's an FDA panel's opinion on anti-obesity devices seeking regulatory approval.
UPDATED: Arena Pharma's weight drug wins the day, shares soar
A committee of non-agency advisers backed approval of the weight drug, lorcaserin, which went down in flames when last in front of the same panel in 2010 .
UPDATED: Arena shares up after FDA briefing on lorcaserin
Oddsmakers are watching the FDA advisory committee that will consider lorcaserin this week very closely.
Allergan subpoenaed over Lap-Band obesity device
Allergan ($AGN) has been slapped with a subpoena from the inspector general of the Department of Health and Human Services regarding the company's Lap-Band obesity treatment device.
Body fat mass might tag risk of bone breakage
Despite its other health downsides, increased weight has previously been linked with higher bone density and lower risk of fracture.
EnteroMedics claws its way back, nabs funding
MedCity News offers an interesting take this morning on EnteroMedics ($ETRM), which has seemingly come back from the brink of disaster and could one day see the FDA bless its obesity treatment Maestro.
GI Dynamics' EndoBarrier implanted in first patients, stock soars
GI Dynamics ($GID) has announced that the first patients have undergone treatment in Australia with the company's EndoBarrier therapy, which is used to treat obesity and Type 2 diabetes.
Vivus shares slide as FDA delays decision on Qnexa
Shares of Vivus slid more than 6% after the news spread that the FDA would delay a final decision on its closely watched application for the weight drug Qnexa.
Obesity startup Obalon pulls in $1.5M
Obesity treatment device startup Obalon Therapeutics has raised $1.5 million to continue ongoing work.
